In Collaboration With:
The COVID-19 Crisis has challenged the world including the Pharmacovigilance systems. One of the most important lessons learned from this crisis is how to keep the pharmacovigilance process uninterrupted specially the critical processes including:
- Monitoring and benefit-risk
- Risk management systems
- Collection & processing individual case safety reports (ICSRs)
- Signal management
- Scheduling, preparation of periodic safety update reports
- Meeting commitments and responding to requests from national medicines authorities
- Interaction between the pharmacovigilance and product quality defect systems
- Communication about safety concerns between marketing authorization holders and national medicines authorities,
- Safety communicating
- Keeping product information up-to-date with the current scientific knowledge
- Implementation of safety variations to marketing authorizations
This webinar will highlight practical examples on business continuity of such process
